TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Estrella Immunopharma ( (ESLA) ) just unveiled an update.
Estrella Immunopharma, Inc. has appointed Dr. Cheng Liu as Director, President, and CEO with an ‘at will’ employment agreement offering a $250,000 annual salary, bonus potential, and equity incentives. The contract allows flexibility for termination and offers severance packages based on the circumstances, highlighting the company’s strategic focus on aligning leadership performance with financial and operational goals.
Find detailed analytics on ESLA stock on TipRanks’ Stock Analysis page.